You know, when I look at the chart $INJ, I think – this is a classic story about how the market overlooks truly important things. Everyone is chasing meme coins with cute puppies, while in the meantime @Injective quietly builds the infrastructure that could change the entire crypto industry. And I'm not saying this for nothing – the latest news from December 2025 shows that something really interesting is starting here.
Do you remember how everyone said that cryptocurrency is just speculation? That no one would use blockchain for real business? Here, Pineapple Financial has just launched a platform for the tokenization of mortgages on #Injective – and these are not some demo projects at $100, but real $716 million already transferred on-chain. They plan to move their entire portfolio of $10 billion – over 29,000 mortgage loans. Imagine: each loan contains over 500 fields of data, all stored on the blockchain, available for auditing, automation, analytics. It’s not just data storage – it’s a foundation for new financial products that were previously impossible. Pineapple chose Injective for its high speed (blocks in 0.64 seconds) and security, with fees being only $0.00008.
Looking at the technical analysis, the picture looks ambiguous but interesting. The price is now 5.64, which is 83% lower than the all-time high. On the hourly chart, I see that the token is forming support in the range of 5.30-5.34, and resistance in the area of 5.70-6.11. This is such a consolidation after that powerful drop that happened at the beginning of December. The candles show a gradual recovery: those large red bodies from the beginning of the period have changed to more balanced trading with the green candles of recent days. Volumes are also interesting – the largest peak was 29,284 at the beginning, now we are in the range of 18-25 thousand, indicating a gradual return of interest, but without panic buying.
Moving averages give mixed signals: MA(7) at 5.59, MA(25) at 5.49, and MA(99) at 5.63 – they are all very close to each other, indicating a period of uncertainty. When all three averages are gathered so tightly, it usually foreshadows a strong move, it’s just not clear in which direction yet. The yellow line MA(7) has already started to bend upwards after being at the bottom, and the purple MA(25) also shows signs of reversal. This could be the beginning of an upward trend, but we need to see confirmation with volumes. The history of Injective shows an interesting pattern: the coin forms a bottom in October, then consolidates for 5-6 months, and then starts a powerful rally. This has worked before – after the drop to $1.45, the project rose to $53, giving a 40x increase. Now we see a similar picture – technically this could be the accumulation zone before the next cycle.
Here’s where it gets interesting – in July 2025, the community approved INJ 3.0, an update that radically changes the tokenomics. They borrowed the idea of halving from Bitcoin, but did it their own way. Now the inflation of $INJ reacts much faster to the staking level, and the parameters for issuing new tokens are seriously limited. Add to this the constant burn auctions (in November, INJ worth $39.5 million was burned), and it turns out that the token could become one of the most deflationary assets in crypto. This is called "ultrasound money" – when the total supply decreases over time. In my estimates, this mechanism could provide long-term positive effects for the price, as long as the network continues to develop.
On November 11, 2025, Injective launched its native EVM mainnet, and this is a significant thing. Now developers from Ethereum can deploy their dApps directly on Injective without any bridges. Everything works on Solidity, but you have the speed of Cosmos and low fees. For me, this is a key moment – Ethereum has a huge base of developers but suffers from high gas fees and limited throughput. Injective offers the best of both worlds: compatibility with Ethereum plus infrastructure that can actually handle serious financial applications. There is already integration with Chainlink Data Streams for reliable oracles – this is critical for derivatives and complex financial products.
Look at the numbers: active users of Injective increased from 6,900 at the beginning of 2025 to 77,600 in December. That’s more than a 10x growth in a year! At the same time, volumes remain significant – $6 billion in perpetuals (in perpetual futures), $10 billion in derivatives overall. The project has risen to second place among L1s in terms of code commits – this shows that development is in full swing. The ecosystem is expanding: there’s iBuild (a platform for creating dApps using AI), plans to support Solana VM in Q1 2026, and filing ETF applications for INJ.
The most difficult thing now is the gap between what is being built and how the market evaluates it. The fundamentals look strong: the technology works, partners are present, users are growing, but the price is falling. This is a typical situation for a bear market when everyone focuses on short-term fluctuations and overlooks long-term trends. Predictions vary – some analysts talk about $56 by the end of 2025 (though this looks optimistic from the current $5.64), others are more conservative with targets of $9-14. But everyone agrees that if Injective continues to execute its roadmap, the potential for growth is enormous. Experts expect a more pronounced bullish phase in March-April 2026, with a possible new ATH in 2027.
I’m not saying you should rush to buy $INJ right now – the crypto market is unpredictable, and even the best project can fall along with the entire market. But looking ahead 1-2 years, #Injective looks like one of those projects that could take off when the market turns around. I like that there are concrete use cases here (mortgage tokenization is a real thing!), strong technology (EVM + Cosmos IBC + speed), and smart tokenomics with a deflationary mechanism. Plus, the fact that Pineapple Financial has become the largest publicly traded holder of INJ (678,353 tokens) shows that institutional players see something valuable here.
Risks? Of course, there are – regulatory uncertainty, general volatility in the crypto market, competition with other L1s. But it is precisely because of these risks that Injective is currently trading at a significant discount to its potential. As they say, the best opportunities arise when everyone is scared. For me @Injective – this is a bet on the future, where traditional finance merges with blockchain, where mortgages, derivatives, loans – all work on-chain, quickly, transparently, and accessibly. And perhaps, in a year or two, we will look at today’s price $INJ and think – why didn’t we buy more then?
